Gina Kolata had a recent piece in the NYT that took the CMS Innovation Center to task for not relying on randomized controlled trials more. I respond in a post over at the AcademyHealth blog.
Gina Kolata had a recent piece in the NYT that took the CMS Innovation Center to task for not relying on randomized controlled trials more. I respond in a post over at the AcademyHealth blog.
Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist. He is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.
Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist. He is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.
Work posted here under copyright © of the authors • Details on the Site Policies page